Project Grant HT94252410350
Award Date
7/1/24
Completion Date
6/30/25
Dollars Obligated
$142K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30310, USA
Similar Awards
The Morehouse School of Medicine (MSM) was awarded a $32,584,200 Project Grant from the U.S. Department of Education's Office of Postsecondary Education under the Higher Education Institutional Aid program (CFDA 84.031). This grant will fund a one-year project from October 1, 2024 to September 30, 2025 to strengthen the management, fiscal operations, and academic quality of this Historically Black Graduate Institution. The grant funding will support activities such as curriculum development,...
The Morehouse School of Medicine (MSM) has been awarded a $2,000,000 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) federal grant program. The funding will support MSM's Prevention Research Center (MSM PRC): Advancing Health Equity and Justice Through Community Powered Implementation Science project over a 5-year period from September 30, 2024 to September 29, 2029. The project...
Meharry Medical College was awarded a $1,054,537 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into novel mechanisms and targeting of neuroendocrine prostate cancer. Through this funding, Meharry Medical College researchers in Nashville, Tennessee will conduct basic, applied, and advanced biomedical research with the goal of transforming health care for service...
The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
The Department of the Army Medical Command awarded a $1,065,567 project grant to Baylor College of Medicine to develop a novel therapeutic strategy for prostate cancer in African American men. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and impactful medical solutions. Funding will support Baylor College of Medicine's...
The Albert Einstein College of Medicine has been awarded a $882,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a novel targeted drug therapy to treat small cell lung cancer (SCLC). The award will support research activities from June 1, 2024 through May 31, 2027. As a highly experienced recipient of federal research grants and contracts, the college has a track record of conducting biomedical research and...
The U.S. Department of the Army's Military Medical Research and Development program (CFDA 12.420) has awarded a $468,672 Project Grant to Georgia College & State University (GC&SU) to conduct the "Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium" research project. This project grant, which runs from September 30, 2024 to September 29, 2028, aims to examine health-seeking behaviors, decision-making, psychosocial effects, and coping mechanisms among Black...
The Department of the Army Medical Command awarded a $202,800 Military Medical Research and Development (CFDA 12.420) project grant to the Icahn School of Medicine at Mount Sinai to conduct research on "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis." The award, with a performance period from September 30, 2025 to September 29, 2026, will support advanced biomedical research focused on transforming healthcare for military service members and the public....
This $779,401 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support lung cancer research led by Tulane University. The 3-year grant, effective July 1, 2024, will fund the Lung Cancer Research Program Idea Development Award, which aims to advance innovative scientific studies around lung cancer prevention, diagnosis, and treatment. As a prime grantee, Tulane University will conduct research and...
The Defense Health Agency awarded a $755,001 Project Grant to The Medical University of South Carolina (MUSC) under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, running from July 1, 2023 to June 30, 2026, supports research on microsomal glutathione transferase as a new target in melanotic melanoma. As a public institution of higher education, MUSC conducts biomedical research and provides healthcare services, with a mission to preserve and optimize...